Drugs / CALCITONIN EEL
CALCITONIN EEL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01623622 | Jul 2012 → May 2015 | hemiplegia | Asahi Kasei Therapeutics Corporation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CALCITONIN EEL | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297974 ↗ |
| Known as | Eel calcitonin | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297974 ↗ |
| Known as | HC-58 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01623622 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL4297974 ↗ |